Cytogen, Inc. announced a private placement of round 4 unregistered nonguaranteed private convertible bond for gross proceeds of KRW 30,000,000,000 on May 17, 2021. The debt maturity date is May 20, 2024. The bonds are 100% convertible into 457,324 common shares at a price or KRW 65,699 per shares.

The conversion period will start on May 20, 2022 and end on April 20, 2024. The payment date is May 20, 2021. The transaction has been approved by the board.